After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Earlier, Yahoo Finance discussed this stock as it revealed Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NYSE listed company, BSX falls under the Healthcare sector while operating within the Medical Devices industry segment. The current market capitalization of Boston Scientific Corp. is $98.65B. A total of 5.83 million shares were traded on the day, compared to an average of 6.66M shares.
In the most recent transaction, Carruthers Wendy sold 6,983 shares of BSX for 66.35 per share on Mar 01 ’24. After the transaction, the EVP, Human Resources now owns 53,788 company shares. In a previous transaction on Feb 26 ’24, Butcher Arthur C sold 9,335 shares at 67.07 per share. BSX shares that EVP& Grp Pres, MedSurg & APAC owns now total 28,937.
Among the insiders who sold shares, Carruthers Wendy disposed of 6,983 shares on Feb 23 ’24 at a per-share price of $66.89. This resulted in the EVP, Human Resources holding 56,508 shares of BSX after the transaction. In another insider transaction, Mirviss Jeffrey B. sold 4,960 shares at $66.35 per share on Feb 21 ’24. Company shares held by the EVP&Pres, Periph Intervent now total 72,604.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, BSX has a high of $68.07 and a low of $47.32.
As of this writing, BSX has an earnings estimate of $0.51 per share for the current quarter. EPS was calculated based on a consensus of 25 estimates, with a high estimate of $0.52 per share and a lower estimate of $0.5. The company reported an EPS of $0.5 in the last quarter, which was 4.20% higher than expectations of $0.48.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. BSX’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $9.45B in debt and $4.27B in liabilities at the time. Its Book Value Per Share was $13.16, while its Total Shareholder’s Equity was $16.62B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BSX is Buy with a score of 4.70.
